Semaglutide has actually been revealed to induce medullary thyroid mobile carcinoma in rodents. Although its clinical relevance to people is unknown, the FDA advises to not administer this drug in Those people with a private or family members heritage of medullary thyroid carcinoma. Semaglutide also poses a danger of pancreatitis and dehydration.20… Read More